Mar 3, 2026 08:31AM
Mar 3, 2026 08:30AM
Nov 20, 2025 11:00AM
Nov 20, 2025 11:00AM
Nov 19, 2025 06:00AM
Nov 10, 2025 04:05PM
Oct 29, 2025 06:00AM Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
Oct 27, 2025 06:00AM
Oct 14, 2025 06:02AM
Oct 14, 2025 06:00AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 2, 2025 06:00AM
Aug 26, 2025 05:21AM BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH)
Aug 25, 2025 06:00AM
Aug 25, 2025 06:00AM
Aug 12, 2025 04:05PM
Jul 28, 2025 06:00AM
Jul 23, 2025 06:00AM
Jun 26, 2025 06:00AM
Jun 26, 2025 06:00AM Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
Jun 2, 2025 06:20AM
Jun 2, 2025 06:00AM
May 13, 2025 06:00AM
May 9, 2025 12:00PM
May 8, 2025 04:05PM
Apr 28, 2025 06:00AM
Apr 24, 2025 06:00AM Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025
Apr 7, 2025 03:55PM
Mar 31, 2025 06:00AM
Mar 27, 2025 06:00AM
Feb 26, 2025 04:05PM
Feb 20, 2025 06:00AM
Feb 12, 2025 06:00AM
Feb 5, 2025 06:00AM Theravance Biopharma to Participate in an Upcoming Investor Conference
Dec 17, 2024 06:00AM
Nov 20, 2024 06:00AM
Nov 12, 2024 04:05PM
Oct 24, 2024 06:00AM
Oct 18, 2024 09:02AM
Oct 18, 2024 09:00AM
Aug 27, 2024 06:00AM Theravance Biopharma to Participate in an Upcoming Investor Conference
Aug 5, 2024 04:05PM
Jul 25, 2024 06:00AM
Jul 22, 2024 06:00AM
May 13, 2024 04:05PM
May 9, 2024 06:00AM
Apr 29, 2024 06:00AM
Apr 10, 2024 06:00AM Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients wit
Feb 26, 2024 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All